ResMed Payments to Acquire Investments increased by 375.8% to $20.13M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 880.6%, from $2.05M to $20.13M. Over 4 years (FY 2021 to FY 2025), Payments to Acquire Investments shows a downward trend with a -26.3% CAGR.
Increases suggest a strategy of diversifying capital or building strategic partnerships, while decreases may indicate a focus on core operations.
This represents cash outflows for the purchase of financial assets, such as equity stakes in other companies, debt secur...
Commonly found in the investing section of the cash flow statement as 'Payments to acquire investments' or 'Purchases of securities'.
other_payments_to_acquire_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.75M | $6.60M | $5.76M | $4.25M | $4.11M | $4.29M | $12.84M | $12.60M | $2.50M | $3.68M | $3.63M | $2.39M | $3.07M | $1.35M | $1.00M | $2.05M | $2.01M | $2.17M | $4.23M | $20.13M |
| QoQ Change | — | +277.1% | -12.7% | -26.3% | -3.3% | +4.4% | +199.3% | -1.9% | -80.2% | +47.2% | -1.5% | -34.2% | +28.7% | -56.1% | -25.9% | +105.3% | -1.9% | +7.9% | +94.7% | +375.8% |
| YoY Change | — | — | — | — | +134.9% | -35.0% | +122.8% | +196.4% | -39.2% | -14.2% | -71.8% | -81.1% | +22.9% | -63.3% | -72.4% | -14.0% | -34.5% | +61.0% | +323.1% | +880.6% |